Section Arrow
Quote
PRE.NASDAQ
- Prenetics Global Limited
Quotes are at least 15-min delayed:2025/07/02 23:02 EDT
Last
 7.91
-0.37 (-4.47%)
Day High 
8.37 
Prev. Close
8.28 
1-M High
10.22 
Volume 
50.30K 
Bid
7.84
Ask
9.5
Day Low
7.84 
Open
8.28 
1-M Low
5.58 
Market Cap 
107.92M 
Currency USD 
P/E 1.43 
%Yield -- 
10-SMA 8.39 
20-SMA 8.12 
50-SMA 7.19 
52-W High 11.99 
52-W Low 3.09474 
Exchange NASDAQ 
Valuation Estimation
EPS (Current/Estimated)
-3.81/--
Enterprise Value
110.94M
Balance Sheet
Book Value Per Share
12.34
Cash Flow
Cash Flow Yield
--
Income Statement
Total Revenue
30.62M
Operating Revenue Per Share
21.41
Industry Comparison
More
Code Name   Last Change Change (%) P/E P/E Range
NEOGNeogen Corp5.23+0.15+2.95%879PE
BIAFbioAffinity Technologies0.29+0.0265+10.06%-- 
DHRDanaher Corp202.5+1.4+0.70%38.97PE
OPKOPKO Health1.34+0.01+0.75%-- 
TMOThermo Fisher Scientific427.76+6.29+1.49%24.72PE
Quotes are at least 15-min delayed：2025/07/02 23:02 EDT
Industry overview quotes are at least 15 minutes delayed
Business Description
Prenetics Global Ltd is a health sciences company dedicated to consumer and clinical health. Its consumer initiative is led by IM8, a new health and wellness brand, and Europa, a U.S. sports distribution company. The clinical division is led by Insighta, focused on multi-cancer early detection technologies. This is followed by ACT Genomics, which has achieved FDA clearance for genomic profiling of solid tumors, and CircleDNA, which uses NGS to offer DNA tests. Each Preneticsunit impacts health by 'enhancing life through science'.
Information provided by: etnet
Terms and Conditions
Bank of China (Hong Kong) Limited
Disclaimer:
This information is provided by ET Net Limited ("ET Net") and/or its third party information providers (the "Sources") and is strictly for reference only. It is not intended to provide any financial or professional advice and any person should not rely upon the same as such. You should obtain relevant and specific professional advice before making any investment decision. Before making an investment decision, you should consider, with the assistance of your professional securities adviser, whether the information is appropriate in light of your particular investment needs, objectives and financial circumstances. ET Net and the Sources endeavor to ensure the accuracy and reliability of the information provided. Notwithstanding the aforesaid, ET Net, the Sources and Bank of China (Hong Kong) Limited do not guarantee or make any representation, warranty or undertaking as to the accuracy, reliability, completeness or timeliness of this information, and accept no responsibility or liability whatsoever (whether in tort or contract or otherwise) for any loss or damage howsoever arising from or in reliance upon the whole or any part of such information.